Table 2.
Question | % Responding ‘Yes’ | |
---|---|---|
1 | Suspicious areas/disease identified on VLE by the physician? | 77% (689/894) |
2 | Did you see any suspicious areas on VLE that you did NOT see on WLE? | 59% (526/894) |
3 | Did you see any suspicious areas on VLE that you did NOT see using advanced imaging (i.e. NBI, FICE, i-Scan, chromatography, or CLE)? | 56% (401/710) |
4 | Did VLE guide tissue acquisition? | 72% (515/714) |
5 | Did findings on VLE guide treatment at the current visit? | 52% (182/352) |
6 | Was either the depth or extent of disease identified on VLE used to determine treatment modality? | 40% (140/353) |
CLE, confocal laser endomicroscopy; NBI, narrow band imaging; VLE, volumetric laser endomicroscopy; WLE, white light endoscopy.